Chapel Allerton Hospital | Dermatology Research

Research site
Chapeltown Road, Leeds, Leeds, England
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


4 of 31
Status: Active
Trial type: Interventional
Funder type: Industry

A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms (VITALISScE™)

This study is open to adults aged 18 and older or above legal age who have systemic sclerosis. People can participate if they have a specific subtype...

Scleroderma, Systemic
Drug: Placebo
Drug: Avenciguat (BI 685509)

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by...

Arthritis, Psoriatic
Drug: Placebo
Drug: Guselkumab

The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.

Plaque Psoriasis
Drug: JNJ-77242113
Drug: Placebo
Locations recently updated

The primary objectives of the study are to evaluate the efficacy of BIIB059 (litifilimab) compared with placebo in reducing skin disease activity mea...

Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Drug: BIIB059 (litifilimab)
Drug: Placebo

Trial conditions

Arthritis (10 trials)
Psoriatic Arthritis (7 trials)
Diffuse Scleroderma (5 trials)
Sclerosis (5 trials)
Systemic Scleroderma (5 trials)
Osteoarthritis (4 trials)
Psoriasis (4 trials)
Knee Osteoarthritis (3 trials)
Rheumatoid Arthritis (3 trials)
Fibrosis (2 trials)

And 24 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems